8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Sep 9, 2014)

Filed September 9, 2014For Securities:ELV

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) issued this Form 8-K on September 9, 2014, to disclose expected communications with securities analysts and investors during a period from September 9 to September 30, 2014. The primary focus of these communications is the reaffirmation of the company's full-year 2014 net income guidance. Management anticipates reporting net income greater than $8.61 per share for the full year. This guidance includes certain adjustments. Specifically, it accounts for net favorable items totaling $0.21 per share recognized in the first two quarters of 2014. Additionally, it factors in an after-tax charge not exceeding $0.20 per share, stemming from a debt refinancing initiated in August 2014. Excluding these specific items, the company continues to project adjusted net income to be greater than $8.60 per share. The guidance explicitly excludes any investment gains or losses beyond those already recorded in the first half of 2014.

Key Highlights

  • 1WellPoint, Inc. (now Elevance Health) reaffirmed its full-year 2014 net income guidance of greater than $8.61 per share.
  • 2The guidance includes net favorable items of $0.21 per share recognized in the first two quarters of 2014.
  • 3An after-tax charge not exceeding $0.20 per share is factored in, related to debt refinancing initiated in August 2014.
  • 4Excluding these items, the company expects adjusted net income to be greater than $8.60 per share.
  • 5The guidance explicitly excludes any investment gains or losses beyond those recorded in the first six months of 2014.
  • 6The company is engaging in meetings with securities analysts and investors from September 9 to September 30, 2014, to discuss these financial projections.
  • 7The filing includes a comprehensive Safe Harbor statement under the Private Securities Litigation Reform Act of 1995, outlining risks and uncertainties.

Frequently Asked Questions

The main purpose of this 8-K filing is to inform investors and analysts that WellPoint, Inc. (now Elevance Health) will be reaffirming its financial guidance for the full fiscal year 2014 during upcoming meetings and presentations.

The company is reaffirming its guidance for full-year 2014 net income to be greater than $8.61 per share. This guidance accounts for specific favorable items and a debt refinancing charge, with an adjusted net income expectation of greater than $8.60 per share, excluding those items.

The guidance includes net favorable items of $0.21 per share from the first two quarters of 2014 and an after-tax charge not to exceed $0.20 per share related to a recent debt refinancing. The adjusted net income guidance excludes these items.

The filing includes a detailed Safe Harbor statement listing numerous risks and uncertainties that could affect future performance. These include regulatory changes (like the Affordable Care Act), healthcare cost trends, competition, enrollment fluctuations, risks associated with government programs (Medicare/Medicaid), potential rating downgrades, litigation, operational and information system risks, and general economic conditions.